<DOC>
	<DOCNO>NCT01387711</DOCNO>
	<brief_summary>This trial conduct explore biological effect skin follow treatment PEP005 Gel , 0.05 % administer two consecutive day , assessed histology .</brief_summary>
	<brief_title>PEP005 Gel - Biological Effects Actinic Keratosis Assessed Histology</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<criteria>1 . Male female patient least 18 year age 2 . Patients AK lesion within contiguous 25 cm2 area upper extremity 3 . Patients 25 cm2 area normal skin upper inner arm 4 . Female subject must either nonchildbearing potential childbearing potential , provide confirm negative urine pregnancy test prior exposure , rule pregnancy 5 . Female subject childbearing potential must willing consent use high effective method contraception 6 . Ability follow study instruction likely complete study requirement 7 . Obtained write informed consent prior studyrelated procedure 1 . Location select treatment area within 5 cm incompletely heal wound within 10 cm suspect basal cell carcinoma ( BCC ) squamous cell carcinoma ( SCC ) 2 . History evidence skin condition study indication would interfere evaluation study medication 3 . Clinical diagnosis/history evidence medical condition would expose subject undue risk significant AE interfere assessment safety , determine Investigator clinical judgment . 4 . Anticipated need inpatient hospitalisation inpatient surgery study period . 5 . Current participation interventional clinical trial 6 . Subjects receive treatment nonmarketed drug product within last two month 7 . Subject know , opinion investigator , unlikely comply Clinical Study Protocol 8 . Females pregnant , childbearing potential wishing become pregnant trial , breast feeding 9 . Undergone cosmetic therapeutic procedure within 2 cm select treatment area 2 week prior screen visit 10 . Use acidcontaining therapeutic product within 2 cm select treatment area 2 week prior screen visit 11 . Use topical salves/topical steroid : within 2 cm select treatment area 2 week prior screen visit 12 . Treatment immunomodulators , cytotoxic drug interferon/interferon inducer , systemic medication suppress immune system UVB last 4 week 13 . Treatment 5FU , imiquimod , diclofenac , photodynamic therapy : within 2 cm select treatment area within 8 week prior screen visit 14 . Use systemic retinoids</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>